Paloma Health Thyroid Test: Specialized At-Home Thyroid Monitoring With Integrated Care
More than 20 million Americans have a thyroid condition. Up to 60% of them do not know it. The butterfly-shaped gland at the base of the neck quietly governs metabolism, energy, mood, and cardiovascular function, and when it fails, everything downstream suffers.
The thyroid produces hormones that regulate basal metabolic rate, body temperature, heart rate, cholesterol metabolism, and neurological development. When thyroid function declines, the symptoms are maddeningly nonspecific: fatigue, weight gain, constipation, dry skin, depression, brain fog, cold intolerance. These symptoms overlap with a dozen other conditions, which is why thyroid disease remains one of the most commonly missed diagnoses in primary care. The American Thyroid Association reports that the lifetime risk of developing a thyroid condition exceeds 12% for the US population, with women affected five to eight times more frequently than men. For Hashimoto’s thyroiditis, the most common cause of hypothyroidism, the autoimmune process can smolder for years before TSH elevates enough to trigger a diagnosis, all while thyroid antibodies progressively destroy functional tissue.
Paloma Health has built an entire care platform around this single organ, combining at-home thyroid testing with thyroid-specialized physician consultations and ongoing medication management into an integrated service that goes far beyond what generalist at-home testing platforms offer.
What Is the Paloma Health Thyroid Test?
Paloma Health is a thyroid-specialized telehealth platform that combines at-home blood testing with ongoing physician care. The Paloma Thyroid Test Kit costs $99 and measures four key thyroid markers from a finger-prick blood sample: TSH, free T4, free T3, and TPO antibodies. The sample is processed through a CLIA-certified laboratory, with results available within approximately five business days.
What distinguishes Paloma from generalist testing platforms is the integrated care model. Beyond testing, Paloma offers physician consultations with thyroid-specialized providers for approximately $45 per month (or $540 per year for the care plan). These consultations include medication prescriptions and adjustments (including natural desiccated thyroid options that many primary care providers do not offer), nutritional guidance for thyroid health, and ongoing monitoring with retesting every three to six months.
The platform is designed not just to detect thyroid dysfunction but to manage it longitudinally. This makes Paloma fundamentally different from competitors that test and report; Paloma tests, diagnoses, treats, and monitors, creating a closed-loop care experience for thyroid patients.
The Science Behind Thyroid Function Testing
Thyroid function assessment requires multiple markers because no single test captures the full picture. TSH (thyroid-stimulating hormone) is the primary screening marker: when the thyroid underproduces hormones, the pituitary gland increases TSH output to stimulate more production. Elevated TSH is the hallmark of hypothyroidism. However, TSH alone can miss important clinical patterns.
Free T4 (thyroxine) and free T3 (triiodothyronine) measure the actual circulating thyroid hormones. T4 is the predominant form produced by the thyroid, while T3 is the biologically active form that cells actually use. Some patients have adequate T4 but impaired T4-to-T3 conversion, a pattern that TSH-only testing misses entirely. These patients may have normal TSH and free T4 but low free T3, explaining persistent symptoms despite “normal” thyroid labs.
TPO (thyroid peroxidase) antibodies detect Hashimoto’s thyroiditis, the autoimmune condition responsible for approximately 90% of hypothyroidism cases in iodine-sufficient countries. Elevated TPO antibodies indicate autoimmune destruction of thyroid tissue and predict future hypothyroidism development even when current thyroid hormone levels remain normal. This predictive value makes TPO antibody testing essential for comprehensive thyroid assessment.
The Endocrine Society and American Thyroid Association guidelines support the use of TSH as the primary screening test, with free T4 and free T3 measured when TSH is abnormal or when clinical suspicion warrants fuller evaluation. TPO antibody testing is recommended when evaluating subclinical hypothyroidism to determine whether autoimmune thyroiditis is the underlying cause, as this influences monitoring frequency and treatment decisions.
Thyroid function and reproductive health are closely interconnected. Subclinical hypothyroidism is associated with menstrual irregularity, anovulation, infertility, and increased risk of pregnancy complications including miscarriage. The American Thyroid Association recommends thyroid screening for all women planning pregnancy or presenting with infertility. This intersection makes Paloma’s thyroid focus directly relevant to the reproductive health monitoring that characterizes the broader Hormonal and Endocrine Testing device category.
What the Paloma Health Thyroid Test Does Well
Paloma’s integrated care model is its defining strength. While other platforms stop at test results and physician review, Paloma continues through diagnosis, treatment, and ongoing management. For a patient diagnosed with Hashimoto’s hypothyroidism, Paloma can prescribe levothyroxine or natural desiccated thyroid (NDT), monitor TSH and free T3/T4 levels through retesting, adjust dosages based on labs and symptoms, and provide nutritional guidance specific to thyroid health, all without the patient leaving their home.
The four-marker panel (TSH, free T4, free T3, TPO antibodies) is more comprehensive than the TSH-only or TSH-plus-free-T4 panels that many primary care providers order. The inclusion of free T3 is particularly important for patients on thyroid replacement therapy, as it reveals whether medication is achieving adequate T3 levels. The addition of TPO antibodies enables Hashimoto’s diagnosis, which many generalist panels omit.
Featured Partner
Invest in the Infrastructure Behind Modern Medicine
As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.
Learn More →The availability of natural desiccated thyroid (NDT) prescriptions differentiates Paloma from many conventional healthcare providers. NDT contains both T4 and T3 in ratios that some patients prefer over synthetic levothyroxine (T4 only). While the Endocrine Society’s guidelines favor levothyroxine as first-line treatment, they acknowledge that some patients report improved well-being on combination T4/T3 therapy. Paloma’s willingness to prescribe NDT gives patients more treatment options.
Pricing, Access, and Practical Realities
The Paloma Thyroid Test Kit costs $99. The optional care plan (physician consultations, prescriptions, ongoing monitoring) costs approximately $45 per month, or $540 per year. For users who only want testing without ongoing care, the $99 test is available as a standalone purchase. For users who want the full care platform, first-year cost including testing and care is approximately $640.
The test is HSA and FSA eligible. CLIA-certified laboratory processing ensures results meet clinical quality standards. The care plan physicians can prescribe medications that are filled through standard pharmacies, with costs varying by insurance coverage and medication selection.
Paloma does not require an existing thyroid diagnosis to use its services. The platform serves both individuals seeking initial thyroid screening and patients with established thyroid conditions who want specialized ongoing management. For patients already on thyroid medication who feel their management could be improved, Paloma offers a second-opinion pathway with thyroid-specialized providers.
The $45/month care plan represents a meaningful ongoing commitment that exceeds the one-time cost of testing through generalist platforms. Users should evaluate whether they need ongoing thyroid care management (making the care plan valuable) or simply want a screening test (making the standalone $99 test sufficient).
Who the Paloma Health Thyroid Test Is Best For
Paloma is ideal for individuals with known or suspected thyroid conditions who want specialized, ongoing management. Patients diagnosed with Hashimoto’s hypothyroidism who feel their current provider is not adequately managing their condition will find Paloma’s thyroid-focused expertise and willingness to try combination therapy options particularly valuable. Women planning pregnancy who want to optimize thyroid function before conceiving represent another strong use case.
Individuals with symptoms consistent with thyroid dysfunction (fatigue, weight changes, mood shifts, cold intolerance, menstrual irregularity) who have been told their “thyroid is normal” based on TSH-only testing may benefit from Paloma’s comprehensive four-marker panel, which can reveal subclinical patterns that TSH alone misses.
Users who simply want a one-time hormone screening without ongoing care commitment may find generalist platforms like Everlywell ($99 thyroid panel) or LetsGetChecked ($99 thyroid panel) more appropriate and equally comprehensive for screening purposes. Individuals with non-thyroid hormonal concerns (reproductive hormones, cortisol, testosterone) will need to supplement Paloma with additional testing from a broader platform, as Paloma focuses exclusively on thyroid health.
How the Paloma Health Thyroid Test Compares
Everlywell Thyroid Test ($99) measures the same four markers (TSH, free T4, free T3, TPO antibodies) at the same price point with CLIA-certified processing and physician review. The difference is downstream: Everlywell provides results and recommendations but does not offer ongoing care management, prescriptions, or medication adjustment. For screening, the two are comparable; for ongoing management, Paloma is the clear choice.
LetsGetChecked Thyroid Test (~$99) offers similar testing with the added benefit of nurse consultations for results interpretation. Like Everlywell, LetsGetChecked does not provide ongoing thyroid care management. The nurse consultation adds clinical context but does not extend to prescription management or longitudinal monitoring.
Traditional endocrinology care through a physician office typically costs $200 to $400 per consultation (before insurance), plus $100 to $300 for laboratory work per visit. For patients without insurance or with high-deductible plans, Paloma’s $99 test plus $45/month care plan may actually represent cost savings compared to multiple specialist visits, particularly when factoring in time, travel, and lost productivity from in-person appointments.
Limitations and Open Questions
Paloma’s thyroid-exclusive focus means it cannot address hormonal health questions beyond thyroid function. Users with reproductive hormone concerns, adrenal dysfunction, or metabolic testing needs will require separate testing through additional platforms. This specialization is a strength for thyroid patients but a limitation for those seeking comprehensive hormonal assessment.
The care plan cost of $540 per year is meaningful and may not be justified for individuals with subclinical findings that do not require treatment. Not every elevated TPO antibody result requires medication; some patients need only monitoring. Users should evaluate whether their thyroid situation warrants ongoing paid management or whether periodic standalone testing is sufficient.
Paloma’s physician consultations are conducted via telehealth, which limits the physical examination component of thyroid care. Thyroid nodules, goiter, and other structural thyroid conditions require palpation and potentially ultrasound imaging that telehealth cannot provide. Users with palpable thyroid abnormalities or suspected structural disease should see a provider in person.
The platform’s inclusion of natural desiccated thyroid prescriptions, while popular with patients, remains a topic of debate within endocrinology. The American Thyroid Association’s guidelines do not endorse NDT as a preferred therapy, citing variability in T3/T4 ratios between preparations. Users interested in NDT should understand both the potential benefits (combined T4/T3, improved symptom satisfaction in some studies) and the limitations (less consistent dosing, limited high-quality comparative data).
What This Means for Your Health
Paloma Health represents a model of disease-specific digital health that may foreshadow the future of chronic condition management. By building an entire care platform around a single organ system, Paloma can develop depth of expertise and operational efficiency that generalist telehealth platforms struggle to match. For the estimated 20 million Americans with thyroid conditions, and the millions more who remain undiagnosed, this specialized approach addresses a real gap in the healthcare system.
Within Healthcare Discovery‘s Five Pillars framework, thyroid function is a critical mediator of how foundational health practices translate into felt well-being. Adequate nutrition (particularly iodine, selenium, zinc, and vitamin D) supports thyroid hormone production and conversion. Quality sleep regulates TSH circadian rhythms. Stress management protects the thyroid from cortisol-mediated suppression. Movement improves thyroid hormone sensitivity and metabolic rate. When thyroid function is compromised, these foundational practices may feel less effective because the hormonal infrastructure that converts healthy behaviors into energy, mood, and metabolic function is impaired.
In the context of the Four Shadows, thyroid dysfunction is a contributor to both cardiovascular disease and metabolic dysfunction. Subclinical hypothyroidism elevates LDL cholesterol, increases arterial stiffness, and raises cardiovascular event risk. Untreated thyroid disease accelerates metabolic decline, promotes weight gain, and impairs glucose metabolism. Paloma’s integrated screening and treatment model provides a pathway to address these thyroid-mediated risks before they contribute to the chronic disease burden that threatens long-term healthspan.
Frequently Asked Questions
What does the Paloma Health Thyroid Test measure?
The test measures four key thyroid markers: TSH (thyroid-stimulating hormone), free T4, free T3, and TPO (thyroid peroxidase) antibodies. This panel can detect hypothyroidism, hyperthyroidism, impaired T4-to-T3 conversion, and Hashimoto’s thyroiditis (autoimmune thyroid disease). The test costs $99 and is processed through a CLIA-certified laboratory.
How much does Paloma Health’s care plan cost?
The care plan costs approximately $45 per month ($540 per year) and includes thyroid-specialized physician consultations, medication prescriptions and adjustments (including natural desiccated thyroid options), nutritional guidance, and ongoing monitoring with periodic retesting. The care plan is optional; the $99 test can be purchased standalone.
Can Paloma prescribe thyroid medication?
Yes. Paloma’s physicians can prescribe levothyroxine (synthetic T4), liothyronine (synthetic T3), and natural desiccated thyroid (NDT) medications. Prescriptions are sent to standard pharmacies. This prescribing capability distinguishes Paloma from testing-only platforms and makes it a comprehensive care solution for thyroid patients.
Is Paloma Health appropriate if I do not have a known thyroid condition?
Yes. The $99 test is appropriate for thyroid screening in individuals experiencing symptoms like fatigue, weight changes, or menstrual irregularity. If results are normal, no ongoing care plan is needed. If results reveal thyroid dysfunction, the care plan provides a pathway to diagnosis and treatment without requiring a separate specialist referral.
Does Paloma test for Hashimoto’s disease?
Yes. The TPO antibody measurement in Paloma’s panel detects Hashimoto’s thyroiditis, the autoimmune condition responsible for approximately 90% of hypothyroidism in iodine-sufficient countries. Elevated TPO antibodies can identify Hashimoto’s even before thyroid hormone levels become abnormal, enabling early monitoring and intervention.
